Mats Novo Nordisk - Search News

News

Novo Nordisk ousts CEO

Novo Nordisk announces CEO transition as share price slips

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release announcing the leadership shake up. Jorgensen will stay on as CEO temporarily for an undetermined period of time “to support a smooth transition” as the company looks for his replacement.

UPI on MSN · 1d

Novo Nordisk CEO will step down amid falling share price and 'recent market challenges'

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he will continue as CEO for a while to smooth the leadership transition.

Fox Business on MSN · 1d

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

The Economist10d

Eli Lilly looks set to steal Novo Nordisk’s weight-loss crown

The momentum is now with Lilly. Visible Alpha, a data firm, expects its sales of obesity drugs to overtake Novo’s by 2027 ...

Pharm Exec3d

Novo Nordisk, Septerna Enter Global Collaboration to Develop Cardiometabolic Medicines

Novo Nordisk and Septerna have entered a global collaboration to develop oral small molecule therapies for obesity, type 2 diabetes, and other cardiometabolic diseases, initially targeting four ...

1don MSN

Novo CEO Was Blindsided on Call by Chairman Before His Departure

When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results